Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel Free FOCL Stock Alerts

FocalTherics (FOCL) Financials

$5.43 -0.05 (-0.91%)
As of 07/10/2026 04:00 PM Eastern
Compare
Annual Income Statements for FocalTherics

Annual Income Statements for FocalTherics

This table shows FocalTherics' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -1.81 4.04 -0.82 -0.39 1.70 -2.08 0.79 -3.14 -23 -21 -29
Consolidated Net Income / (Loss)		 -1.81 4.04 -0.82 -0.39 1.70 -2.08 0.79 -3.14 -23 -21 -29
Net Income / (Loss) Continuing Operations		 -1.81 4.04 -0.82 -0.39 1.70 -2.08 0.79 -3.14 -23 -21 -29
Total Pre-Tax Income 		-0.99 4.68 -0.35 0.02 2.46 -1.45 1.01 -2.24 -23 -20 -29
Total Operating Income		 0.53 0.41 -2.43 -1.51 2.47 0.33 -1.82 -4.55 -22 -22 -25
Total Gross Profit		 15 17 18 19 24 22 21 26 27 29 30
Total Revenue		 35 37 43 45 50 51 50 59 67 69 71
Operating Revenue		 35 37 43 45 50 51 50 59 67 69 71
Total Cost of Revenue		 20 20 25 25 27 28 29 33 40 41 41
Operating Cost of Revenue		 20 20 25 25 27 28 29 33 40 41 41
Total Operating Expenses		 14 17 20 21 21 22 23 30 49 51 55
Selling, General & Admin Expense		 3.48 3.47 4.12 4.11 4.74 5.30 6.68 7.65 16 15 18
Marketing Expense		 8.05 9.32 11 12 12 11 12 18 25 27 27
Research & Development Expense		 2.92 4.07 4.66 4.68 4.18 5.49 3.85 5.26 7.70 8.36 9.66
Total Other Income / (Expense), net		 -1.52 4.26 2.08 1.53 -0.01 -1.78 2.84 2.31 -0.80 1.95 -4.11
Interest & Investment Income		 - - - - - - - 0.25 1.19 0.61 -3.11
Other Income / (Expense), net		 0.76 0.11 -1.09 0.62 0.15 -1.66 2.67 2.06 -1.99 1.35 -1.00
Income Tax Expense		 0.82 0.63 0.47 0.41 0.76 0.63 0.22 0.90 0.71 0.31 0.44
Basic Earnings per Share		 ($0.07) $0.14 ($0.02) ($0.01) $0.05 ($0.06) $0.02 ($0.10) ($0.63) ($0.55) ($0.78)
Weighted Average Basic Shares Outstanding		 25.02M 27.82M 28.96M 29.00M 29.02M 29.15M 32.13M 34.39M 37.00M 37.29M 37.44M
Diluted Earnings per Share		 ($0.07) $0.13 ($0.02) ($0.01) $0.05 ($0.06) $0.02 ($0.10) ($0.63) ($0.55) ($0.78)
Weighted Average Diluted Shares Outstanding		 25.02M 29.37M 28.96M 29.00M 29.62M 29.15M 32.42M 34.39M 37.00M 37.29M 37.44M
Weighted Average Basic & Diluted Shares Outstanding		 25.38M 28.73M 29.00M 29.00M 29.14M 29.17M 33.47M 36.91M 37.10M 37.39M 37.48M

Quarterly Income Statements for FocalTherics

This table shows FocalTherics' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q1 2026
Period end date 3/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -7.44 -9.08
Consolidated Net Income / (Loss)		 -7.44 -9.08
Net Income / (Loss) Continuing Operations		 -7.44 -9.08
Total Pre-Tax Income 		-7.30 -8.94
Total Operating Income		 -6.31 -7.37
Total Gross Profit		 5.99 8.15
Total Revenue		 14 18
Operating Revenue		 14 18
Total Cost of Revenue		 8.27 9.67
Operating Cost of Revenue		 8.27 9.67
Total Operating Expenses		 12 16
Selling, General & Admin Expense		 3.65 5.79
Marketing Expense		 6.07 7.12
Research & Development Expense		 2.58 2.60
Total Other Income / (Expense), net		 -0.99 -1.57
Interest & Investment Income		 0.02 -1.71
Other Income / (Expense), net		 -1.01 0.14
Income Tax Expense		 0.14 0.15
Basic Earnings per Share		 ($0.20) ($0.24)
Weighted Average Basic Shares Outstanding		 37.39M 37.48M
Diluted Earnings per Share		 ($0.20) ($0.24)
Weighted Average Diluted Shares Outstanding		 37.39M 37.48M
Weighted Average Basic & Diluted Shares Outstanding		 - 37.48M

Annual Cash Flow Statements for FocalTherics

This table details how cash moves in and out of FocalTherics' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 2.65 8.85 -2.38 -0.62 1.60 4.65 25 17 -22 -17 -11
Net Cash From Operating Activities		 1.32 1.27 -3.67 0.20 4.26 2.42 5.03 -3.24 -16 -15 -16
Net Cash From Continuing Operating Activities		 1.32 1.27 -3.68 0.20 4.27 2.42 5.03 -3.24 -16 -15 -16
Net Income / (Loss) Continuing Operations		 -1.81 4.04 -0.82 -0.39 1.70 -2.08 0.79 -3.14 -23 -21 -29
Consolidated Net Income / (Loss)		 -1.81 4.04 -0.82 -0.39 1.70 -2.08 0.79 -3.14 -23 -21 -29
Depreciation Expense		 1.09 1.08 1.89 1.84 2.11 2.57 2.17 1.72 2.12 2.78 3.41
Amortization Expense		 - - - - - - - - - 0.00 2.87
Non-Cash Adjustments To Reconcile Net Income		 2.13 -3.83 -2.66 0.03 0.58 1.45 2.51 2.67 8.06 5.15 4.01
Changes in Operating Assets and Liabilities, net		 -0.09 -0.02 -2.09 -1.29 -0.12 0.48 -0.44 -4.48 -2.99 -2.04 2.56
Net Cash From Investing Activities		 -0.59 -0.40 -2.44 -1.80 -1.72 -2.46 -1.85 -2.54 -4.81 -4.46 -5.72
Net Cash From Continuing Investing Activities		 -0.59 -0.40 -2.44 -1.80 -1.72 -2.46 -1.86 -2.54 -4.81 -4.46 -5.72
Purchase of Property, Plant & Equipment		 -0.68 -1.24 -0.76 -0.69 -0.44 -0.65 -0.44 -0.66 -1.30 -1.42 -1.21
Acquisitions		 -0.02 -0.16 -0.54 -0.50 -0.04 -0.13 -0.10 -0.15 -0.59 -0.25 -0.83
Other Investing Activities, net		 -0.01 -0.06 -1.24 -1.01 -1.24 -1.68 -1.31 -1.74 -2.91 -2.79 -3.67
Net Cash From Financing Activities		 2.29 8.00 3.45 1.35 -0.75 3.91 23 23 -1.01 5.02 8.61
Net Cash From Continuing Financing Activities		 2.29 8.00 3.45 1.35 -0.75 3.91 23 23 -1.01 5.02 8.61
Repayment of Debt		 0.22 -0.61 -0.65 -0.92 -1.42 -1.03 -2.05 -1.23 -2.02 -1.93 -2.92
Issuance of Debt		 0.75 2.09 3.30 2.26 0.77 4.86 0.39 0.27 0.73 6.82 12
Other Financing Activities, net		 0.14 0.00 0.14 0.00 -0.10 0.07 0.50 0.74 0.29 0.13 0.00
Effect of Exchange Rate Changes		 -0.38 -0.02 0.28 -0.37 -0.20 0.78 -0.66 -0.42 0.30 -2.89 2.97

Quarterly Cash Flow Statements for FocalTherics

This table details how cash moves in and out of FocalTherics' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q1 2026
Period end date 3/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -6.31 -5.44
Net Cash From Operating Activities		 -5.34 -2.97
Net Cash From Continuing Operating Activities		 -5.34 -2.97
Net Income / (Loss) Continuing Operations		 -7.44 -9.08
Consolidated Net Income / (Loss)		 -7.44 -9.08
Depreciation Expense		 0.75 0.90
Amortization Expense		 0.00 1.68
Non-Cash Adjustments To Reconcile Net Income		 0.44 0.67
Changes in Operating Assets and Liabilities, net		 0.91 2.87
Net Cash From Investing Activities		 -1.30 -0.75
Net Cash From Continuing Investing Activities		 -1.30 -0.75
Purchase of Property, Plant & Equipment		 -0.05 -0.41
Acquisitions		 -0.58 -0.03
Other Investing Activities, net		 -0.68 -0.32
Net Cash From Financing Activities		 -1.25 -1.37
Net Cash From Continuing Financing Activities		 -1.25 -1.37
Repayment of Debt		 -0.72 -0.70
Issuance of Debt		 -0.53 -0.67
Effect of Exchange Rate Changes		 1.59 -0.34

Annual Balance Sheets for FocalTherics

This table presents FocalTherics' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 42 49 56 56 60 67 87 108 101 89 79
Total Current Assets		 36 43 48 46 47 55 76 97 87 73 57
Cash & Equivalents		 15 23 24 22 23 30 53 68 48 31 20
Note & Lease Receivable		 1.11 0.93 1.28 1.64 1.41 1.26 1.42 1.63 1.53 1.75 1.30
Accounts Receivable		 12 9.62 14 14 13 14 12 14 20 19 21
Inventories, net		 6.68 8.45 8.10 8.25 9.18 9.76 8.49 13 17 19 13
Other Current Assets		 0.54 0.48 0.59 0.44 0.50 0.45 0.66 0.71 0.73 1.31 1.30
Plant, Property, & Equipment, net		 2.31 2.91 4.42 0.00 4.57 4.52 4.09 4.49 7.16 8.09 10
Total Noncurrent Assets		 3.72 3.49 4.38 4.76 7.75 7.45 7.05 6.85 6.58 8.73 11
Noncurrent Note & Lease Receivables		 0.64 0.31 0.09 0.03 0.00 - - - - 0.00 0.55
Goodwill		 2.62 2.54 2.90 2.76 2.71 2.95 2.73 2.58 2.67 2.51 2.83
Intangible Assets		 0.04 0.16 0.63 0.97 0.86 0.93 0.82 0.78 1.20 1.13 1.80
Noncurrent Deferred & Refundable Income Taxes		 - 0.01 0.20 0.37 0.48 0.46 1.02 0.89 0.81 0.87 1.09
Other Noncurrent Operating Assets		 0.41 0.47 0.55 0.62 3.69 3.12 2.48 2.61 1.90 4.23 5.17
Total Liabilities & Shareholders' Equity		 42 49 56 56 60 67 87 108 101 89 79
Total Liabilities		 26 23 26 27 29 35 31 32 38 47 60
Total Current Liabilities		 18 16 19 19 20 26 20 23 31 39 37
Short-Term Debt		 3.54 2.17 4.03 4.78 4.46 8.76 3.11 3.69 4.45 8.99 8.11
Accounts Payable		 6.63 6.27 7.58 7.21 6.79 6.97 6.24 7.11 12 13 12
Current Deferred Revenue		 1.74 1.98 2.76 2.21 2.12 3.30 3.86 4.33 4.48 6.90 7.10
Current Deferred & Payable Income Tax Liabilities		 0.68 0.38 0.18 0.14 0.31 0.16 0.57 0.23 - -0.01 0.19
Current Employee Benefit Liabilities		 0.59 0.60 0.69 0.70 0.71 0.85 0.80 0.85 0.95 1.02 1.19
Other Taxes Payable		 1.32 1.28 1.29 1.35 1.35 1.44 1.49 1.66 1.88 2.33 2.14
Other Current Liabilities		 3.19 3.11 2.85 2.87 3.88 4.79 4.26 5.35 6.19 6.95 6.63
Total Noncurrent Liabilities		 8.56 7.50 6.73 7.97 9.22 9.09 10 8.33 7.78 7.64 22
Long-Term Debt		 0.64 0.40 1.00 1.53 1.07 1.40 5.58 3.84 2.21 2.25 16
Capital Lease Obligations		 0.32 0.33 0.63 0.98 0.73 0.68 0.49 0.35 0.48 0.36 0.36
Noncurrent Deferred Revenue		 0.55 0.35 0.68 1.11 1.47 1.13 0.50 0.28 0.71 0.37 0.97
Other Noncurrent Operating Liabilities		 7.05 6.42 4.42 4.35 5.94 5.89 3.87 3.86 4.38 4.66 5.22
Total Equity & Noncontrolling Interests		 16 26 30 29 31 32 57 77 63 42 19
Total Preferred & Common Equity		 16 26 30 29 31 32 57 77 63 42 19
Total Common Equity		 16 26 30 29 31 32 57 77 63 42 19
Common Stock		 67 72 84 80 79 86 106 127 139 155 157
Retained Earnings		 -46 -41 -48 -46 -43 -49 -45 -45 -70 -99 -129
Treasury Stock		 -1.24 -1.20 -1.37 -1.31 -1.04 -1.13 -1.05 -0.96 -0.88 -1.02 -1.02
Accumulated Other Comprehensive Income / (Loss)		 -3.88 -4.15 -4.33 -4.29 -3.86 -3.74 -4.06 -4.10 -4.96 -12 -8.34

Quarterly Balance Sheets for FocalTherics

This table presents FocalTherics' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2026
Period end date 3/31/2026
Total Assets		 72
Total Current Assets		 50
Cash & Equivalents		 15
Note & Lease Receivable		 0.68
Accounts Receivable		 20
Inventories, net		 13
Other Current Assets		 1.69
Plant, Property, & Equipment, net		 10
Total Noncurrent Assets		 11
Noncurrent Note & Lease Receivables		 1.03
Goodwill		 2.77
Intangible Assets		 1.72
Noncurrent Deferred & Refundable Income Taxes		 1.09
Other Noncurrent Operating Assets		 4.89
Total Liabilities & Shareholders' Equity		 72
Total Liabilities		 62
Total Current Liabilities		 38
Short-Term Debt		 6.70
Accounts Payable		 13
Current Deferred Revenue		 7.82
Current Deferred & Payable Income Tax Liabilities		 0.18
Current Employee Benefit Liabilities		 1.23
Other Taxes Payable		 2.17
Other Current Liabilities		 6.87
Total Noncurrent Liabilities		 24
Long-Term Debt		 18
Capital Lease Obligations		 0.44
Noncurrent Deferred Revenue		 1.06
Other Noncurrent Operating Liabilities		 5.35
Total Equity & Noncontrolling Interests		 10
Total Preferred & Common Equity		 10
Total Common Equity		 10
Common Stock		 158
Retained Earnings		 -138
Treasury Stock		 -1.02
Accumulated Other Comprehensive Income / (Loss)		 -8.87

Annual Metrics And Ratios for FocalTherics

This table displays calculated financial ratios and metrics derived from FocalTherics' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 25,383,461.00 28,727,616.00 28,997,866.00 28,997,866.00 29,141,566.00 29,165,316.00 33,466,136.00 36,910,925.00 37,103,779.00 37,392,086.00 37,392,086.00
DEI Adjusted Shares Outstanding		 25,383,461.00 28,727,616.00 28,997,866.00 28,997,866.00 29,141,566.00 29,165,316.00 33,466,136.00 36,910,925.00 37,103,779.00 37,392,086.00 37,392,086.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.07 0.14 -0.03 -0.01 0.06 -0.07 0.02 -0.09 -0.63 -0.55 -0.78
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 8.13% 6.90% 14.62% 4.44% 12.39% 0.98% -2.01% 18.21% 13.38% 3.82% 1.63%
EBITDA Growth		 255.15% -32.77% -202.39% 158.23% 396.28% -73.79% 143.53% -125.76% -2,701.82% 16.94% -7.32%
EBIT Growth		 149.19% -59.62% -777.28% 74.79% 394.92% -150.77% 163.58% -394.69% -858.29% 12.67% -23.09%
NOPAT Growth		 125.24% -3.95% -578.08% 1,592.29% -93.30% -86.51% -721.73% -122.91% -381.26% -1.40% -11.11%
Net Income Growth		 -192.37% 323.15% -120.25% 52.74% 538.66% -222.65% 138.06% -496.12% -646.60% 12.13% -42.08%
EPS Growth		 -250.00% 285.71% -115.38% 50.00% 600.00% -220.00% 133.33% -581.50% -554.72% 12.77% -41.82%
Operating Cash Flow Growth		 207.42% -3.50% -388.91% 105.45% 2,029.22% -43.37% 108.31% -164.30% -401.90% 9.45% -11.60%
Free Cash Flow Firm Growth		 242.40% -122.94% -911.96% 453.73% -110.75% 133.75% -208.31% -589.15% -155.70% 12.63% -1.49%
Invested Capital Growth		 -41.66% 26.54% 115.68% -26.13% 54.46% -5.95% -2.43% 36.55% 26.05% 7.99% 1.03%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 42.74% 46.08% 41.43% 43.17% 46.76% 44.11% 41.81% 43.90% 40.40% 41.42% 42.54%
EBITDA Margin		 6.79% 4.27% -3.81% 2.13% 9.39% 2.44% 6.05% -1.32% -32.60% -26.08% -27.54%
Operating Margin		 1.51% 1.10% -5.67% -3.36% 4.90% 0.65% -3.66% -7.72% -32.79% -32.03% -35.01%
EBIT Margin		 3.68% 1.39% -8.21% -1.98% 5.20% -2.62% 1.70% -4.23% -35.77% -30.08% -36.44%
Profit (Net Income) Margin		 -5.17% 10.79% -1.91% -0.86% 3.37% -4.09% 1.59% -5.32% -35.05% -29.66% -41.47%
Tax Burden Percent		 183.79% 86.45% 232.54% -1,690.01% 69.01% 143.41% 78.38% 139.94% 103.14% 101.55% 101.52%
Interest Burden Percent		 -76.41% 897.78% 9.98% -2.57% 93.75% 108.99% 119.39% 89.88% 95.01% 97.10% 112.11%
Effective Tax Rate		 0.00% 13.55% 0.00% 1,790.02% 30.99% 0.00% 21.61% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 6.29% 7.24% -19.63% 246.65% 15.29% 1.75% -11.37% -21.70% -80.03% -69.97% -74.49%
ROIC Less NNEP Spread (ROIC-NNEP)		 25.95% -16.12% -24.23% 381.96% 15.33% 14.41% -18.37% -21.80% -64.06% -53.49% 79.99%
Return on Net Nonoperating Assets (RNNOA)		 -16.95% 12.28% 16.71% -247.97% -9.56% -8.38% 13.16% 16.99% 46.47% 30.93% -20.01%
Return on Equity (ROE)		 -10.65% 19.52% -2.93% -1.32% 5.73% -6.63% 1.79% -4.71% -33.56% -39.04% -94.50%
Cash Return on Invested Capital (CROIC)		 58.91% -16.19% -92.92% 276.71% -27.52% 7.88% -8.92% -52.61% -103.08% -77.66% -75.51%
Operating Return on Assets (OROA)		 3.19% 1.15% -12.98% -1.59% 4.55% -2.10% 1.09% -2.55% -22.83% -21.90% -30.52%
Return on Assets (ROA)		 -4.48% 8.89% -3.01% -0.69% 2.94% -3.28% 1.02% -3.21% -22.37% -21.59% -34.73%
Return on Common Equity (ROCE)		 -10.65% 19.52% -5.67% -1.32% 5.73% -6.63% 1.79% -4.71% -33.56% -39.04% -94.50%
Return on Equity Simple (ROE_SIMPLE)		 -11.55% 15.71% -2.71% -1.35% 5.53% -6.49% 1.40% -4.09% -37.20% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 0.37 0.36 -1.70 25 1.70 0.23 -1.43 -3.19 -15 -16 -17
NOPAT Margin		 1.06% 0.95% -3.97% 56.72% 3.38% 0.45% -2.87% -5.41% -22.95% -22.42% -24.51%
Net Nonoperating Expense Percent (NNEP)		 -19.66% 23.36% 4.59% -135.31% -0.04% -12.66% 6.99% 0.10% -15.97% -16.49% -154.48%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -3.77% -21.89% -28.77% -39.49%
Cost of Revenue to Revenue		 57.26% 53.92% 58.57% 56.83% 53.24% 55.89% 58.19% 56.10% 59.60% 58.58% 57.46%
SG&A Expenses to Revenue		 9.93% 9.26% 9.59% 9.17% 9.41% 10.41% 13.39% 12.98% 24.22% 21.97% 25.13%
R&D to Revenue		 8.34% 10.86% 10.86% 10.43% 8.30% 10.79% 7.72% 8.93% 11.52% 12.05% 13.70%
Operating Expenses to Revenue		 41.23% 44.99% 47.10% 46.53% 41.86% 43.47% 45.46% 51.63% 73.19% 73.45% 77.55%
Earnings before Interest and Taxes (EBIT)		 1.29 0.52 -3.53 -0.89 2.62 -1.33 0.85 -2.49 -24 -21 -26
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 2.38 1.60 -1.64 0.95 4.73 1.24 3.02 -0.78 -22 -18 -19
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 3.24 2.73 1.88 4.18 4.70 3.08 4.66 3.10 1.93 6.34
Price to Tangible Book Value (P/TBV)		 0.00 3.62 3.09 2.16 4.73 5.35 3.29 4.87 3.30 2.11 8.32
Price to Revenue (P/Rev)		 0.00 2.22 1.92 1.20 2.55 2.96 3.50 6.05 2.92 1.18 1.74
Price to Earnings (P/E)		 0.00 20.60 0.00 0.00 75.70 0.00 220.54 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 4.85% 0.00% 0.00% 1.32% 0.00% 0.45% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 11.46 5.40 4.41 8.22 10.32 10.50 17.52 7.20 2.71 5.44
Enterprise Value to Revenue (EV/Rev)		 0.00 1.68 1.49 0.86 2.21 2.58 2.62 5.04 2.30 0.90 1.80
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 39.42 0.00 40.54 23.52 105.91 43.21 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 121.04 0.00 0.00 42.43 0.00 154.11 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 176.80 0.00 1.52 65.29 570.91 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 49.56 0.00 192.99 26.10 54.38 25.93 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 1.35 0.00 126.84 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.29 0.11 0.19 0.26 0.20 0.34 0.16 0.10 0.11 0.27 1.26
Long-Term Debt to Equity		 0.06 0.03 0.05 0.09 0.06 0.06 0.11 0.05 0.04 0.06 0.84
Financial Leverage		 -0.65 -0.76 -0.69 -0.65 -0.62 -0.58 -0.72 -0.78 -0.73 -0.58 -0.25
Leverage Ratio		 2.38 2.20 1.88 1.91 1.95 2.02 1.75 1.47 1.50 1.81 2.72
Compound Leverage Factor		 -1.82 19.72 0.19 -0.05 1.82 2.20 2.08 1.32 1.43 1.76 3.05
Debt to Total Capital		 22.32% 10.15% 31.58% 20.32% 16.95% 25.25% 13.93% 9.32% 10.18% 21.44% 55.65%
Short-Term Debt to Total Capital		 17.55% 7.59% 22.47% 13.32% 12.07% 20.42% 4.72% 4.36% 6.34% 16.62% 18.52%
Long-Term Debt to Total Capital		 4.77% 2.56% 9.12% 6.99% 4.89% 4.84% 9.22% 4.95% 3.83% 4.83% 37.14%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 77.68% 89.85% 168.42% 79.68% 83.04% 74.74% 86.07% 90.68% 89.83% 78.56% 44.35%
Debt to EBITDA		 1.89 1.82 -6.92 7.64 1.32 8.74 3.04 -10.12 -0.33 -0.64 -1.25
Net Debt to EBITDA		 -4.77 -12.65 23.15 -15.73 -3.63 -15.59 -14.65 76.72 1.88 1.07 -0.20
Long-Term Debt to EBITDA		 0.40 0.46 -2.00 2.63 0.38 1.67 2.01 -5.38 -0.12 -0.14 -0.84
Debt to NOPAT		 12.14 8.15 -4.39 0.29 3.68 47.10 -6.41 -2.47 -0.47 -0.75 -1.41
Net Debt to NOPAT		 -30.54 -56.73 22.23 -0.59 -10.07 -84.06 30.93 18.72 2.67 1.25 -0.23
Long-Term Debt to NOPAT		 2.59 2.06 -1.27 0.10 1.06 9.02 -4.24 -1.31 -0.18 -0.17 -0.94
Altman Z-Score		 0.00 2.43 3.96 1.37 3.21 2.75 4.06 7.48 2.63 -0.05 -0.92
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.03 2.70 4.91 2.40 2.41 2.11 3.75 4.17 2.84 1.85 1.54
Quick Ratio		 1.62 2.13 4.01 1.95 1.91 1.72 3.30 3.60 2.27 1.33 1.16
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 3.47 -0.80 -8.07 29 -3.07 1.04 -1.12 -7.73 -20 -17 -18
Operating Cash Flow to CapEx		 226.73% 102.98% -1,120.51% 71.43% 959.60% 372.32% 1,131.04% -493.31% -1,244.95% -1,033.24% -1,355.00%
Free Cash Flow to Firm to Interest Expense		 1.53 0.00 0.00 0.00 -18.72 8.65 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.58 0.00 0.00 0.00 26.03 20.17 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.32 0.00 0.00 0.00 23.32 14.76 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.87 0.82 0.82 0.80 0.87 0.80 0.64 0.60 0.64 0.73 0.84
Accounts Receivable Turnover		 3.49 3.52 3.71 3.30 3.83 3.84 3.82 4.42 3.92 3.55 3.47
Inventory Turnover		 2.90 2.67 3.04 3.12 3.08 3.00 3.18 3.14 2.72 2.26 2.53
Fixed Asset Turnover		 14.38 14.35 11.70 0.00 0.00 11.20 11.57 13.73 11.47 9.11 7.63
Accounts Payable Turnover		 3.02 3.13 3.63 3.45 3.84 4.13 4.39 4.96 4.06 3.18 3.26
Days Sales Outstanding (DSO)		 104.54 103.73 98.45 110.48 95.28 95.12 95.54 82.51 93.14 102.77 105.08
Days Inventory Outstanding (DIO)		 125.80 136.71 120.03 117.09 118.57 121.51 114.74 116.37 134.32 161.30 144.30
Days Payable Outstanding (DPO)		 120.84 116.52 100.49 105.90 95.17 88.28 83.08 73.66 89.83 114.92 112.06
Cash Conversion Cycle (CCC)		 109.50 123.92 117.99 121.67 118.68 128.35 127.20 125.22 137.63 149.16 137.32
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 4.35 5.50 12 8.76 14 13 12 17 21 23 23
Invested Capital Turnover		 5.94 7.61 4.95 4.35 4.52 3.88 3.97 4.01 3.49 3.12 3.04
Increase / (Decrease) in Invested Capital		 -3.10 1.15 6.36 -3.10 4.77 -0.81 -0.31 4.54 4.42 1.71 0.24
Enterprise Value (EV)		 0.00 63 64 39 111 131 130 297 154 63 127
Market Capitalization		 0.00 83 82 54 128 151 175 357 195 82 123
Book Value per Share		 $0.63 $1.01 $1.05 $0.99 $1.06 $1.10 $1.94 $2.29 $1.71 $1.15 $0.52
Tangible Book Value per Share		 $0.52 $0.91 $0.93 $0.86 $0.94 $0.97 $1.82 $2.19 $1.60 $1.05 $0.40
Total Capital		 20 29 36 36 37 43 66 85 70 54 44
Total Debt		 4.51 2.91 5.67 7.28 6.27 11 9.17 7.87 7.13 12 24
Total Long-Term Debt		 0.96 0.73 1.64 2.51 1.81 2.07 6.07 4.18 2.69 2.61 16
Net Debt		 -11 -20 -18 -15 -17 -19 -44 -60 -41 -19 3.91
Capital Expenditures (CapEx)		 0.58 1.24 0.66 0.28 0.44 0.65 0.44 0.66 1.30 1.42 1.21
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 5.92 5.86 8.16 9.47 8.63 7.77 5.65 9.76 13 11 7.68
Debt-free Net Working Capital (DFNWC)		 22 29 32 32 32 38 59 77 61 42 28
Net Working Capital (NWC)		 18 27 28 27 28 29 56 74 56 33 20
Net Nonoperating Expense (NNE)		 2.18 -3.69 -0.89 26 0.01 2.31 -2.22 -0.05 8.08 5.03 12
Net Nonoperating Obligations (NNO)		 -11 -20 -18 -20 -17 -19 -44 -60 -42 -19 3.91
Total Depreciation and Amortization (D&A)		 1.09 1.08 1.89 1.84 2.11 2.57 2.17 1.72 2.12 2.78 6.27
Debt-free, Cash-free Net Working Capital to Revenue		 16.90% 15.64% 39.21% 21.12% 17.13% 15.27% 11.33% 16.55% 18.92% 16.29% 10.89%
Debt-free Net Working Capital to Revenue		 62.10% 77.39% 154.71% 70.79% 63.63% 74.55% 118.40% 131.12% 90.86% 60.95% 39.88%
Net Working Capital to Revenue		 51.99% 71.58% 135.33% 60.14% 54.78% 57.34% 112.18% 124.86% 84.21% 48.00% 28.39%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.07) $0.14 ($0.02) ($0.01) $0.05 ($0.06) $0.02 ($0.09) ($0.57) ($0.53) ($0.78)
Adjusted Weighted Average Basic Shares Outstanding		 25.02M 27.82M 28.96M 29.00M 29.02M 29.15M 32.13M 34.39M 37.00M 37.29M 37.44M
Adjusted Diluted Earnings per Share		 ($0.07) $0.13 ($0.02) ($0.01) $0.05 ($0.06) $0.02 ($0.09) ($0.57) ($0.53) ($0.78)
Adjusted Weighted Average Diluted Shares Outstanding		 25.02M 29.37M 28.96M 29.00M 29.62M 29.15M 32.42M 34.39M 37.00M 37.29M 37.44M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 25.38M 28.73M 29.00M 29.00M 29.14M 29.17M 33.47M 36.91M 37.10M 37.39M 37.48M
Normalized Net Operating Profit after Tax (NOPAT)		 0.37 0.36 -1.70 -1.05 1.70 0.23 -1.43 -3.19 -15 -16 -17
Normalized NOPAT Margin		 1.06% 0.95% -3.97% -2.35% 3.38% 0.45% -2.87% -5.41% -22.95% -22.42% -24.51%
Pre Tax Income Margin		 -2.81% 12.48% -0.82% 0.05% 4.88% -2.85% 2.03% -3.80% -33.98% -29.21% -40.85%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.57 0.00 0.00 0.00 16.01 -11.12 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.16 0.00 0.00 0.00 10.40 1.92 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.31 0.00 0.00 0.00 13.29 -16.54 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -0.09 0.00 0.00 0.00 7.69 -3.50 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for FocalTherics

This table displays calculated financial ratios and metrics derived from FocalTherics' official financial filings.

Metric Q1 2025 Q1 2026
Period end date 3/31/2025 3/31/2026
DEI Shares Outstanding		 37,392,086.00 37,481,986.00
DEI Adjusted Shares Outstanding		 37,392,086.00 37,481,986.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.20 -0.24
Growth Metrics		 - -
Revenue Growth		 0.00% 24.85%
EBITDA Growth		 0.00% 29.20%
EBIT Growth		 0.00% 1.24%
NOPAT Growth		 0.00% -16.75%
Net Income Growth		 0.00% -22.01%
EPS Growth		 0.00% -20.00%
Operating Cash Flow Growth		 0.00% 44.37%
Free Cash Flow Firm Growth		 0.00% 0.00%
Invested Capital Growth		 0.00% 0.00%
Revenue Q/Q Growth		 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00%
Profitability Metrics		 - -
Gross Margin		 42.01% 45.73%
EBITDA Margin		 -45.99% -26.08%
Operating Margin		 -44.22% -41.35%
EBIT Margin		 -51.27% -40.56%
Profit (Net Income) Margin		 -52.18% -50.99%
Tax Burden Percent		 101.98% 101.62%
Interest Burden Percent		 99.79% 123.73%
Effective Tax Rate		 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% -216.26%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -296.98%
Return on Net Nonoperating Assets (RNNOA)		 0.00% -286.05%
Return on Equity (ROE)		 0.00% -502.31%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% -41.69%
Return on Assets (ROA)		 0.00% -52.42%
Return on Common Equity (ROCE)		 0.00% -502.31%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -4.42 -5.16
NOPAT Margin		 -30.95% -28.95%
Net Nonoperating Expense Percent (NNEP)		 0.00% 80.72%
Return On Investment Capital (ROIC_SIMPLE)		 - -14.80%
Cost of Revenue to Revenue		 57.99% 54.27%
SG&A Expenses to Revenue		 25.60% 32.51%
R&D to Revenue		 18.10% 14.58%
Operating Expenses to Revenue		 86.23% 87.09%
Earnings before Interest and Taxes (EBIT)		 -7.32 -7.22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -6.56 -4.65
Valuation Ratios		 - -
Price to Book Value (P/BV)		 0.00 13.80
Price to Tangible Book Value (P/TBV)		 0.00 24.87
Price to Revenue (P/Rev)		 0.00 1.88
Price to Earnings (P/E)		 0.00 0.00
Dividend Yield		 0.00% 0.00%
Earnings Yield		 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 7.52
Enterprise Value to Revenue (EV/Rev)		 0.00 2.01
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00
Leverage & Solvency		 - -
Debt to Equity		 0.00 2.45
Long-Term Debt to Equity		 0.00 1.79
Financial Leverage		 0.00 0.96
Leverage Ratio		 0.00 7.13
Compound Leverage Factor		 0.00 8.83
Debt to Total Capital		 0.00% 71.01%
Short-Term Debt to Total Capital		 0.00% 19.24%
Long-Term Debt to Total Capital		 0.00% 51.77%
Preferred Equity to Total Capital		 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00%
Common Equity to Total Capital		 0.00% 28.99%
Debt to EBITDA		 0.00 -1.41
Net Debt to EBITDA		 0.00 -0.56
Long-Term Debt to EBITDA		 0.00 -1.03
Debt to NOPAT		 0.00 -1.37
Net Debt to NOPAT		 0.00 -0.54
Long-Term Debt to NOPAT		 0.00 -1.00
Altman Z-Score		 0.00 -0.41
Noncontrolling Interest Sharing Ratio		 0.00% 0.00%
Liquidity Ratios		 - -
Current Ratio		 0.00 1.34
Quick Ratio		 0.00 0.94
Cash Flow Metrics		 - -
Free Cash Flow to Firm (FCFF)		 0.00 -25
Operating Cash Flow to CapEx		 -11,613.04% -733.83%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00
Efficiency Ratios		 - -
Asset Turnover		 0.00 1.03
Accounts Receivable Turnover		 0.00 3.77
Inventory Turnover		 0.00 3.14
Fixed Asset Turnover		 0.00 7.26
Accounts Payable Turnover		 0.00 3.34
Days Sales Outstanding (DSO)		 0.00 96.84
Days Inventory Outstanding (DIO)		 0.00 116.09
Days Payable Outstanding (DPO)		 0.00 109.16
Cash Conversion Cycle (CCC)		 0.00 103.77
Capital & Investment Metrics		 - -
Invested Capital		 0.00 20
Invested Capital Turnover		 0.00 7.47
Increase / (Decrease) in Invested Capital		 0.00 20
Enterprise Value (EV)		 0.00 149
Market Capitalization		 73 139
Book Value per Share		 $0.00 $0.27
Tangible Book Value per Share		 $0.00 $0.15
Total Capital		 0.00 35
Total Debt		 0.00 25
Total Long-Term Debt		 0.00 18
Net Debt		 0.00 9.73
Capital Expenditures (CapEx)		 0.05 0.41
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 4.55
Debt-free Net Working Capital (DFNWC)		 0.00 20
Net Working Capital (NWC)		 0.00 13
Net Nonoperating Expense (NNE)		 3.03 3.93
Net Nonoperating Obligations (NNO)		 0.00 9.73
Total Depreciation and Amortization (D&A)		 0.75 2.58
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 6.14%
Debt-free Net Working Capital to Revenue		 0.00% 26.41%
Net Working Capital to Revenue		 0.00% 17.36%
Earnings Adjustments		 - -
Adjusted Basic Earnings per Share		 $0.00 ($0.24)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 37.48M
Adjusted Diluted Earnings per Share		 $0.00 ($0.24)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 37.48M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 37.48M
Normalized Net Operating Profit after Tax (NOPAT)		 -4.42 -5.16
Normalized NOPAT Margin		 -30.95% -28.95%
Pre Tax Income Margin		 -51.17% -50.18%
Debt Service Ratios		 - -
EBIT to Interest Expense		 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00
Payout Ratios		 - -
Dividend Payout Ratio		 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

FocalTherics (NASDAQ: FOCL) posted a weaker start to fiscal 2026, with revenue growing year over year but losses widening and cash burn remaining elevated. The latest quarter suggests the company is still investing heavily, but it has not yet turned that growth into operating leverage.

  • Revenue increased 25.0% year over year to $17.8 million in Q1 2026 from $14.3 million in Q1 2025, showing solid top-line growth.
  • Gross profit improved to $8.1 million from $6.0 million, indicating better volume and/or pricing support.
  • Gross margin expanded modestly to about 45.7% from 42.0% last year.
  • Cash and equivalents remained meaningful at $15.0 million at quarter-end, giving the company some liquidity cushion.
  • Net income improved slightly on a pre-tax basis compared with the scale of revenue growth, suggesting the business is scaling, even if profitability is still out of reach.
  • R&D expense was essentially flat year over year at about $2.6 million, suggesting continued product investment without a major step-up in spending.
  • SG&A rose materially to $5.8 million from $3.7 million, which may reflect higher overhead to support growth.
  • Marketing expense increased to $7.1 million from $6.1 million, showing the company is spending to drive adoption.
  • Balance sheet leverage remains notable, with total liabilities of $62.0 million versus total equity of just $10.1 million.
  • Retained earnings are deeply negative at $137.7 million, reflecting a long history of accumulated losses.
  • Operating loss widened to $7.4 million from $6.3 million a year ago, despite higher revenue.
  • Net loss increased to $9.1 million from $7.4 million in Q1 2025.
  • Operating cash flow was negative at $3.0 million, indicating the business is still burning cash from core operations.
  • Total cash declined sharply during the quarter, with net cash and equivalents down $5.4 million after investing, financing, and FX effects.
  • Debt remains significant at $6.7 million in short-term debt and $17.6 million in long-term debt, adding financial risk.

Bottom line: FocalTherics is growing revenue, but profitability is moving in the wrong direction and cash flow remains negative. Investors will likely want to see evidence that revenue growth can eventually outpace operating expenses before the stock can sustain a stronger rerating.

07/11/26 10:50 AM ETAI Generated. May Contain Errors.

FocalTherics Financials - Frequently Asked Questions

According to the most recent income statement we have on file, FocalTherics' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

FocalTherics' net income appears to be on an upward trend, with a most recent value of -$29.25 million in 2025, rising from -$1.81 million in 2015. The previous period was -$20.58 million in 2024. View FocalTherics' forecast to see where analysts expect FocalTherics to go next.

FocalTherics' total operating income in 2025 was -$24.69 million, based on the following breakdown:
  • Total Gross Profit: $30.00 million
  • Total Operating Expenses: $54.70 million

Over the last 10 years, FocalTherics' total revenue changed from $35.04 million in 2015 to $70.53 million in 2025, a change of 101.3%.

FocalTherics' total liabilities were at $59.58 million at the end of 2025, a 27.0% increase from 2024, and a 127.1% increase since 2015.

In the past 10 years, FocalTherics' cash and equivalents has ranged from $14.75 million in 2015 to $67.54 million in 2022, and is currently $20.45 million as of their latest financial filing in 2025.

Over the last 10 years, FocalTherics' book value per share changed from 0.63 in 2015 to 0.52 in 2025, a change of -17.1%.


Related Companies

Financial statements for NASDAQ:FOCL last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel